Pharmaceutical Investing Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
Pharmaceutical Investing Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm
pharmaceutical investing IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
